Shibayama Y, Alkhoury C, Nemazanyy I, Henneman N, Cagnard N, Girard M, Atsumi T, Panasyuk G.
Class 3 Phosphatidyl Inositol-3 Kinase Promotes Hepatic Glucocorticoid Receptor Stability and Transcriptional Activity Acta Physiologica, in press
IF: 6.311
{ 352件 }
Shibayama Y, Alkhoury C, Nemazanyy I, Henneman N, Cagnard N, Girard M, Atsumi T, Panasyuk G.
Class 3 Phosphatidyl Inositol-3 Kinase Promotes Hepatic Glucocorticoid Receptor Stability and Transcriptional Activity Acta Physiologica, in press
IF: 6.311
Satoka Shiratori-Aso, Daigo Nakazawa, Saori Nishio, Yusho Ueda, Mina Eguchi, Ai Yokoyama, Junpei Yoshikawa, Takashi Kudo, Kanako Watanabe-Kusunoki, Sayo Takeda-Otera, Junya Yamamoto, Naoko Matsuoka, Nobuharu Kaneshima, Fumihiko Hattanda, Sari Iwasaki, Takahiro Tsuji, Yuichiro Fukasawa, Tatsuya Atsumi.
Soluble interleukin-2 receptor predicts treatment outcome in patients with autoimmune tubulointerstitial nephritis. A preliminary study Frontiers in Medicine, in press.
IF 5.091
Kuniyuki Aso, Michihito Kono, Nobuya Abe, Yuichiro Fujieda, Masaru Kato, Tatsuya Atsumi Anti-ganglionic nicotinic acetylcholine receptor α3 subunit antibody as a potential biomarker associated with lupus enteritis Modern Rheumatology, in press
IF: 3.023
Shuhei Takeyama, Nobuya Abe, Tatsuya Atsumi.
Autosplenectomy.
European Journal of Internal Medicine 2022, in press.
IF 4.624
Yuki Oe, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi Switching from insulin degludec plus dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide improves glycemic variability in patients with type 2 diabetes: a preliminary prospective observation study J Diabetes Res, in press.
IF: 4.011
Takahashi Y, Kameda H, Miya A, Nomoto H, Nakamura A, Nishimura H, Kimura H, Suzuki M, Konno S, Shimizu A, Matsuno Y, Okamoto M, Motegi H, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Miyoshi H, A tsumi T.
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Pituitary, in press.
IF: 4.107
Abe N, Kono Michihito, Kono Michihiro, Ohnishi N, Sato T, Tarumi M, Yoshimura M, Sato T, Karino K, Shimizu Y, Fujieda Y, Kato M, Hasebe R, Oku K, Murakami M, Atsumi T.
Glycogen synthase kinase 3β/CCR6-positive bone marrow cells correlate with disease activity in multicentric Castleman disease-TAFRO.
Br. J. Haematol. in press.
IF=6.998
Atsumi T, Tanaka Y, Matsubara T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Westhovens R, Ching D, Messina OD, Burmester GR, Bartok B, Pechonkina A, Kondo S, Yin Z, Guo Y, Tasset C, Sundy JS, Takeuchi T Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3) Modern Rheumatology, in press.
IF: 3.023
Oe Y, Kameda H, Nomoto H, Sakamoto K, Soyama T, Cho KY, Nakamura A, Iwasaki K, Abo D, Kudo K, Miyoshi H, Atsumi T.
Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: a case report Medicine, in press
IF: 1.889
第47回日本神経内分泌学会 若手研究奨励賞 関崎 知紀先生